| Similar Articles |
|---|
 |
The Motley Fool
September 6, 2007
Ryan Fuhrmann |
Bio-Reference Labs Passes the Test Small-cap lab-testing firm Bio-Reference Labs third-quarter results beat analysts projections by a decent margin, again proving it can compete with the big boys in the highly competitive New York metro area.   |
The Motley Fool
March 12, 2007
Ryan Fuhrmann |
Esoteric Results at Bio-Reference Labs Bio-Reference Labs is a small firm in the lab-testing field, but worth a look from investors. |
The Motley Fool
February 8, 2007
Rich Duprey |
Foolish Forecast: LabCorp Tests Positive The clinical lab-testing outfit is set to report its fourth-quarter 2006 earnings. Investors, here is what you can expect to see. |
The Motley Fool
February 15, 2007
Ryan Fuhrmann |
LabCorp Takes Names Things are going well at LabCorp, but not so well at Quest Diagnostics. Still, the long-term attractiveness of the lab testing industry is favorable as the industry consolidates and demographics support increasing healthcare services. |
The Motley Fool
October 24, 2006
Ryan Fuhrmann |
LabCorp's Positive Results The good times continue. After taking a major client from Quest Diagnostics, the company reports strong third-quarter earnings. |
The Motley Fool
June 7, 2007
Ryan Fuhrmann |
Big Gains for a Little Lab-Tester While bigger competitors stumble over each other, Bio-Reference keeps growing. This company may just be a welcome investment alternative as its two larger peers keep getting in each other's way. |
The Motley Fool
July 26, 2007
Ryan Fuhrmann |
LabCorp Leaps Forward LabCorp continues to fire on all cylinders. Investors, take note. |
The Motley Fool
July 25, 2007
Ryan Fuhrmann |
The Latest Procedure From Quest Diagnostics Quest Diagnostics took a hit earlier this year from the loss of a major contract, but the lab testing firm isn't down for the count. |
The Motley Fool
April 20, 2007
Ryan Fuhrmann |
Diagnosing Quest Diagnostics Quest should recover from a recent, painful contract loss. Shares trade for a reasonable 17.5 times earnings, and even lower multiple of free cash flow. |
The Motley Fool
April 27, 2007
Ryan Fuhrmann |
LabCorp Tests Positive LabCorp is doing well focusing on managed care -- so far. Recent results were "outstanding by every measure" and could signal even better things to come. Investors, take note. |
The Motley Fool
April 19, 2007
Ryan Fuhrmann |
Quest Diagnostics Becomes Un-United: Fool by Numbers The lab-testing firm released first-quarter 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
July 21, 2005
W.D. Crotty |
The Lab Is Fab Laboratory Corporation of America produces more healthy results. Quest is a better value today based on earnings growth, but both companies are an excellent bet. |
The Motley Fool
July 24, 2006
Ryan Fuhrmann |
The Quest for Market Share Quest Diagnostics' second-quarter earnings mostly meet expectations. What might the future hold for investors? |
Managed Care
April 2007
Scott Kober |
Managed Care Seeks More from Clinical Laboratories Contracting advantage has sometimes been with the nationwide labs, but health plans are getting serious about price, service, and patient data. |
The Motley Fool
October 5, 2006
Rich Smith |
Great Chemistry at Lab Corp UnitedHealth Group has canceled its lab-testing contract with Quest and named Lab Corp. as its new service provider. This is an interesting situation for investors. |
The Motley Fool
April 26, 2007
Ryan Fuhrmann |
LabCorp Measures Up: Fool by Numbers The lab testing firm released results for the first quarter 2007: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
January 24, 2006
Rich Smith |
Foolish Forecast: Silicon Labs Gels The semiconductor company is up 47% over the past 52 weeks. Can its winning streak continue? |
The Motley Fool
January 10, 2007
Rich Duprey |
Foolish Forecast: Greener Forest Labs The pharmaceutical firm stands tall against competition. When the company releases its third-quarter 2007 financials, investors shouldn't have to reach for their medicine chest. |
The Motley Fool
February 13, 2009
Brian Orelli |
Lynch Would Love This Company Double-digit revenue growth in this market is nothing to sneeze at, but that's what LabCorp has delivered. |
The Motley Fool
June 11, 2007
Billy Fisher |
Big Dollars in Diagnostic Deals CIGNA extends multi-year deals to a pair of powerhouses. The Quest agreement is a comfort to investors, who now know that Quest will continue to be a contracted provider for one of the nation's largest health insurers. |
The Motley Fool
June 15, 2005
Bobby Shethia |
A New Test for Quest The medical testing leader hopes to improve its steady performance via the rapidly growing gene-testing market. But sustained growth will require hefty capital expenditures. Investors, take note. |
The Motley Fool
October 24, 2006
Ryan Fuhrmann |
Lab Corp's Healthy Prognosis: Fool by Numbers The lab-testing firm released fiscal third-quarter 2006 earnings: Here are the quick details investors need to know. |
InternetNews
January 26, 2006
David Needle |
Microsoft Makes Big Internet Research Play Microsoft reported a major investment and research effort with the announcement of Live Labs, a partnership between its MSN online division and Microsoft Research. |
The Motley Fool
October 26, 2004
Rich Smith |
Silicon Labs Goes Boom! After laying down a solid quarterly report, the company added a caution for the fourth quarter, sending the stock down 21%. |
The Motley Fool
February 17, 2005
Rich Smith |
LabCorp Tests Positive The results show strong bottom-line growth for the health-care test provider. Compared to the pricier Quest, it's at least a relative bargain price at which investors can own an interest in this essential piece of the health-care market. |
The Motley Fool
July 31, 2006
Stephen D. Simpson |
A SLAB of Missed Opportunity Watch lists are good; actually buying undervalued stocks on those lists can be priceless. Which list should chip maker Silicon Labs be on? |
The Motley Fool
July 22, 2005
W.D. Crotty |
Silicon Labs: Chips, Cheap The chip maker still struggles, but it's also banking cash. The company's shares are selling for 20.1 times expected 2006 earnings. For a cash-rich company with Silicon Labs' anticipated growth, that's downright cheap. |
The Motley Fool
October 20, 2005
Rich Smith |
LabCorp: Boring Can Be Good The company is firmly on track toward this year's goal of $440 million to $465 million in free cash flow. Should the company hit even the low end of that guidance, it would be valued at under 16 times FCF, smack dab in between its projected growth rate and its return on equity. |
